Pittsford, NY, United States of America

Melinda A Borrello


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Rochester, NY (US) (2007)
  • Pittsford, NY (US) (2011)

Company Filing History:


Years Active: 2007-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Melinda A Borrello: Innovator in Cancer Research

Introduction

Melinda A Borrello is a prominent inventor based in Pittsford, NY (US). She has made significant contributions to the field of cancer research, particularly in understanding the genetic factors associated with breast and bladder cancer. Her work has led to the development of innovative methods for diagnosing and treating these conditions.

Latest Patents

Melinda A Borrello holds 2 patents related to her groundbreaking research. Her latest patents include a novel human gene that is differentially expressed in human carcinoma. This invention focuses on methods for treating or preventing disorders in subjects, utilizing C35 polypeptides in immunogenic compositions or vaccines. These compositions aim to induce antibody or T cell-mediated immunity against tumor cells expressing the C35 gene. Additionally, her patents cover diagnostic methods for detecting carcinomas, including human breast carcinomas, and the formulation of C35 polypeptides for various therapeutic applications.

Career Highlights

Borrello is affiliated with the University of Rochester, where she continues her research and innovation in cancer biology. Her work has been instrumental in advancing the understanding of cancer genetics and developing potential therapeutic strategies.

Collaborations

Throughout her career, Melinda has collaborated with notable colleagues, including Maurice Zauderer and Elizabeth E Evans. These partnerships have enhanced her research efforts and contributed to the success of her innovative projects.

Conclusion

Melinda A Borrello's contributions to cancer research exemplify the impact of innovation in medicine. Her patents and ongoing work at the University of Rochester continue to pave the way for advancements in cancer diagnosis and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…